Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds. Based ...

The U.S. Food and Drug Administration approved the vaccine, Nuvaxovid, but limited its use to older adults and people over 12 ...

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

Boehringer Ingelheim’s long-awaited phase 3 lung disease data received a muted reception from analysts who labelled ...

At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) in Q1 CY2025, with sales falling 3.1% year on year to $195.9 million.

Healthcare tech company Premier (NASDAQ:PINC) reported Q1 CY2025 results , but sales fell by 8.9% year on year to $261.4 ...

BioMarin Pharmaceutical has agreed to acquire Inozyme Pharma for $4.00 per share in a $270m all-cash transaction. This will ...

The deal, announced on Monday, highlights AMD's efforts to produce more of its chips on American soil amid global trade ...

Stonebrook Private Inc. slightly reduced its position in Johnson & Johnson, selling 2,057 shares, yet still holds $3.24 ...